首页> 外国专利> SYSTEMS, DEVICES, AND METHODS FOR ALLEVIATING GLUCOTOXICITY AND RESTORING PANCREATIC BETA-CELL FUNCTION IN ADVANCED DIABETES MELLITUS

SYSTEMS, DEVICES, AND METHODS FOR ALLEVIATING GLUCOTOXICITY AND RESTORING PANCREATIC BETA-CELL FUNCTION IN ADVANCED DIABETES MELLITUS

机译:在高级糖尿病患者中缓解糖毒性和恢复胰岛β细胞功能的系统,装置和方法

摘要

Systems, methods and/or devices for treating diabetes mellitus by alleviating glucotoxicity and restoring pancreatic beta-cell function, comprising at least a first memory for storing data inputs corresponding at least to one or more components in a patient's present insulin dosage regimen, and data inputs corresponding at least to the patient's blood-glucose-level measurements determined at a plurality of times, and a processor operatively connected to the at least first memory. The processor determines from the data inputs whether and by how much to vary at least one of the components of the patient's present insulin dosage regimen. Also disclosed is establishing the patient's current glycemic state relative to a desired glycemic range and determining from at least one of a plurality of the data corresponding to the patient's blood glucose-level measurements whether and by how much to adjust at least one of the components in the patient's present insulin dosage regimen.
机译:通过减轻糖毒性和恢复胰腺β细胞功能来治疗糖尿病的系统,方法和/或装置,包括至少第一存储器,用于存储对应于患者当前胰岛素剂量方案中至少一个或多个成分的数据输入,以及数据输入至少对应于多次确定的患者的血糖水平测量值,以及可操作地连接到至少第一存储器的处理器。处理器从数据输入中确定患者当前胰岛素剂量方案中至少一种成分是否改变以及改变多少。还公开了建立相对于期望血糖范围的患者当前血糖状态,并从与患者血糖水平测量值相对应的多个数据中的至少一个确定是否以及通过多少来调节其中的至少一种成分。患者当前的胰岛素剂量方案。

著录项

  • 公开/公告号EP3030140A4

    专利类型

  • 公开/公告日2017-02-08

    原文格式PDF

  • 申请/专利权人 HYGIEIA INC.;

    申请/专利号EP20140833783

  • 发明设计人 BASHAN ERAN;HODISH ISRAEL;

    申请日2014-08-05

  • 分类号A61B5;A61M31;G01N33/48;A61M5/172;A61M5/142;A61B5/145;G06F19;

  • 国家 EP

  • 入库时间 2022-08-21 14:04:43

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号